Retinopathy secondary to treatment with interferon beta-1a in a patient with multiple sclerosis;Retinopatía secundaria a tratamiento con interferón beta 1a en paciente con esclerosis múltiple

Revista de Neurologia

Volumn 40, Issue 8, 2005, Pages 482-484

  Mallada Frechín, Javier ^a   Abellan Miralles I ^b   Alfaro Beltra, M L ^a   Medrano, V ^a   Munoz Gil M B ^a   Fernandez Izquierdo S ^a   Piqueras Rodriguez L ^a  

^a HOSPITAL GENERAL DE ELDA   (Spain)

^b HOSPITAL MARINA BAIXA   (Spain)

Author keywords

Cotton wool spots; Interferon beta; Microinfarction; Multiple sclerosis; Retinopathy; Treatment

Indexed keywords

ALPHA INTERFERON; BETA1A INTERFERON; GLATIRAMER; INTERFERON BETA SERINE; BETA INTERFERON;

ADULT; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMPLEMENT ACTIVATION; COTTON; FEMALE; HEPATITIS C; HUMAN; LITERATURE; MULTIPLE SCLEROSIS; NEOPLASM; PHYSICIAN; RECURRENT DISEASE; REMISSION; RETINA BLOOD VESSEL; RETINA BLOOD VESSEL OCCLUSION; RETINA DISEASE; RETINOPATHY; SYMPTOM; VISUAL DISORDER; PATHOLOGY; SUBCUTANEOUS DRUG ADMINISTRATION;

ADULT; FEMALE; HUMANS; INJECTIONS, SUBCUTANEOUS; INTERFERON-BETA; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; RETINAL DISEASES;

EID: 24644491331     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.4008.2005132     Document Type: Article

References (16)

1. Matthews B. Symptoms and signs of multiple sclerosis. In Compston A, Ebers G, Lassmann H, McDonald I, Matthews B, Werkele H, eds. McAlpine's multiple sclerosis. 3 ed. London: Churchill-Livingstone; 1998. p. 145-90.
2. Kappos L. Interferons in relapsing-remitting multiple sclerosis. In Cohen J, Rudick RA, eds. Multiple sclerosis therapeutics. 2 ed. London: Martin Dunitz; 2003. p. 325-46.
3. Ikebe T, Nakatsuka K, Goto M, Sakai Y, Kageyama S. A case of retinopathy induced by intravenous administration interferon. Folia Ophthalmol Jpn Ka-Kiyo 1990; 41: 2291-6.
4. Kawano T, Shigehira M, Uto H, Nakama T, Kato J, Hayashi K, el al. Retinal complications during interferon therapy for chronic hepatitis C. Am J Gastroenterol 1996; 91: 309-13.
5. Hejny C, Sternberg P, Lawson DH, Greiner K, Aaberg TM Jr. Retinopathy associated with high-dose interferon alfa-2b therapy. Am J Ophthalmol 2001; 131: 782-7.
6. Guyer DR, Tiedeman J, Yannuzzi LA, Slakter JS, Parke D, Kelley J, et al. Interferon-associated retinopathy. Arch Ophthalmol 1993; 111: 350-6.
7. Hayasaka S, Nagaki Y, Matsumoto M, Sato S. Interferon associated retinopathy. Br J Ophthalmol 1998; 82: 323-5.
8. Tu KL, Bowyer J, Schofield K, Harding S. Severe interferon associated retinopathy. Br J Ophthalmol 2003; 87: 247-8.
9. Willson RL, Ross RD, Willson LM, Cohen G, Redfield TL, Gitter KA. Interferon-associated retinopathy in a young, insulin-dependent diabetic patient. Retina 2000; 20: 413-5.
10. Saito H, Ebinuma H, Nagata H, Inagaki Y, Saito Y, Wakabayashi K, et al. Interferon-associated retinopathy in a uniform regimen of natural interferon-alpha therapy for chronic hepatitis C. Liver 2001; 21: 192-7.
11. Kadayifcilar S, Boyacioglu S, Kart H, Gursoy M, Aydin P. Ocular complications with high-dose interferon alpha in chronic active hepatitis. Eye 1999; 13: 241-6.
12. Cuthbertson FM, Davies M, McKibbin M. Is screening for interferon retinopathy in hepatitis C justified? Br J Ophthalmol 2004; 88: 1518-20.
13. Soushi S, Kobayashi F, Obazawa H, Higasawa K, Shiraishi K, Itakura M, et al. Evaluation of risk factors of interferon-associated retinopathy in patients with type C chronic active hepatitis. J Jpn Ophthalmol Soc 1996; 100: 69-76.
14. Neubauer AS, Hoops JP. Interferon-induced retinopathy in asymptomatic cancer patients. Ophthalmology 2002; 109: 821-2.
15. Sugano S, Suzuki T, Watanabe M, Ohe K, Ishii K, Okajima T. Retinal complications and plasma C5a levels during interferon alpha therapy for chronic hepatitis C. Am J Gastroenterol 1998; 93: 2441-4.
16. Sommer S, Sablon JC, Zaoui M, Rozot P, Hosni A. Interferon beta-1b retinopathy during a treatment for multiple sclerosis. J Fr Ophtalmol 2001; 24: 509-12.